WHENJune 10, 2006 @ 8:00am - 5:00pm
WHERE
INFO
REGISTER

Challenges to the 21st Century Medicine

San Diego Bio-Pharma Conference 2006

June 10th, 2006, Price Center, UCSD

 

(Greeings from San Diego city Mayor, Mr Jerry Sanders)

As the world has entered a new millennium, new health challenges have emerged. Among those are:

Diabetes— A diabetes epidemic is underway. At least 171 million people worldwide have diabetes; this figure is likely to increase to at least 366 million by 2030. Around 3.2 million deaths every year are attributable to complications of diabetes; six deaths every minute.

Obesity— The prevalence of overweight and obesity is increasing worldwide at an alarming rate in both developing and developed countries. An estimated 30 percent of U.S. adults aged 20 years and older – over 60 million people – are obese.

Cancers— More than 11 million people are diagnosed with cancer every year. It is estimated that there will be 16 million new cases every year by 2020. Cancer causes 7 million deaths every yearor 12.5% of deaths worldwide.

Infectious diseases— Over 40 million people have been infected byHIVworldwide, and more than 3 million people died of AIDS-related illnesses in 2005. Globally, an estimated 170 million persons are chronically infected withHCVand 3 to 4 million people are newly infected each year. The outbreaks of highly pathogenic H5N1avian influenzabegan in south-east Asia in mid-2003 and have now spread to a few parts of Europe . Almost half of the 192 confirmed human cases have led to death. The threat of pandemic influenza is arising.

With thedevelopment costofover $1 billion per new drug and the decreasing number of new drugs approved in the recent years, the pharmaceutical industry needs to reduce the development cost while coping with the increasingly challenging diseases and meeting the higher safety standards from FDA.

Facing the challenges, great progresses have been made from research to new drug development in San Diego local academic institutes, and biotechnology and pharmaceutical companies. In this one-day conference, you will learn a wealth of information about new discoveries, innovative technologies, exciting new drugs for treatment, as well as new business models for cost-effective research, preclinical and clinical studies.

As the world has entered a new millennium, new health challenges have emerged. Among those are:

Diabetes — A diabetes epidemic is underway. At least 171 million people worldwide have diabetes; this figure is likely to increase to at least 366 million by 2030. Around 3.2 million deaths every year are attributable to complications of diabetes; six deaths every minute.

Obesity — The prevalence of overweight and obesity is increasing worldwide at an alarming rate in both developing and developed countries. An estimated 30 percent of U.S. adults aged 20 years and older – over 60 million people – are obese.

Cancers — More than 11 million people are diagnosed with cancer every year. It is estimated that there will be 16 million new cases every year by 2020. Cancer causes 7 million deaths every yearor 12.5% of deaths worldwide.

Infectious diseases — Over 40 million people have been infected by HIV worldwide, and more than 3 million people died of AIDS-related illnesses in 2005. Globally, an estimated 170 million persons are chronically infected with HCV and 3 to 4 million people are newly infected each year. The outbreaks of highly pathogenic H5N1 avian influenza began in south-east Asia in mid-2003 and have now spread to a few parts of Europe . Almost half of the 192 confirmed human cases have led to death. The threat of pandemic influenza is arising.

With the development cost of over $1 billion per new drug and the decreasing number of new drugs approved in the recent years, the pharmaceutical industry needs to reduce the development cost while coping with the increasingly challenging diseases and meeting the higher safety standards from FDA.

Facing the challenges, great progresses have been made from research to new drug development in San Diego local academic institutes, and biotechnology and pharmaceutical companies. In this one-day conference, you will learn a wealth of information about new discoveries, innovative technologies, exciting new drugs for treatment, as well as new business models for cost-effective research, preclinical and clinical studies.